Table 3. Summary of data collected.
| Method | Respondent type | Ghana | Kenya | Burkina Faso | Total | |||
|---|---|---|---|---|---|---|---|---|
| Non-MVT | MVT | Non-MVT | MVT | Non-MVT | MVT | |||
| Facility audits a | CT facilities | 0 | 4 | 0 | 3 | 0 | 3 | 10 |
| Human resource audits | MoH staff | 5 | 10 | 3 | 6 | 0 | 0 | 24 |
| Research centre staff | 23 | 24 | 0 | 5 | 25 | 43 | 120 | |
| Investigators interviews | Senior CT investigators | 0 | 1 | 0 | 1 | 0 | 10 | 12 |
| Health providers interviews | MoH staff | 9 | 2 | 3 | 6 | 10 | 19 | 49 |
| MVT clinicians | 2 | 14 | 0 | 5 | 3 | 6 | 30 | |
| MVT fieldworkers | 0 | 0 | 0 | 0 | 0 | 8 | 8 | |
| Health managers interviews | District health managers | 4 | 0 | 0 | 0 | 2 | 0 | 6 |
| Regional health managers | 2 | 0 | 0 | 0 | 2 | 0 | 4 | |
| National health managers | 0 | 0 | 0 | 0 | 4 | 0 | 4 | |
| Focus group discussion | MVT fieldworkers | 3 | 3 | 0 | 3 | 0 | 0 | 9 |
MVT: Malaria vaccine trial
a MVT facilities audited include a referral hospital (Ghana = 1), health centres (Ghana = 3; Kenya = 1), dispensaries (Kenya = 2), community clinics (Burkina Faso = 2) and a clinical trial facility (Burkina Faso = 1).